GET THE APP

Inflammatory Reactions in Microenvironments, Leading to Melanomag
Journal of Clinical and Cellular Immunology

Journal of Clinical and Cellular Immunology
Open Access

ISSN: 2155-9899

+44 1223 790975

Short Communication - (2017) Volume 8, Issue 3

Inflammatory Reactions in Microenvironments, Leading to Melanomagenesis

Koichi Furukawa1,2*, Maiko Miyata1, Mariko Kambe1, Rika Takeuchi1, Robiul H. Bhuiyan1,2, Pu Zhang1,2, Yuhsuke Ohmi1 and Keiko Furukawa1
1Chubu University College of Life and Health Sciences, Kasugai, 487-8501, Japan
2Department of Biochemistry II, Nagoya University Graduate School of Medicine, 466-0065, Japan
*Corresponding Author: Koichi Furukawa, Department of Biochemistry II, Nagoya University Graduate School of Medicine, 466-0065, Japan, Tel: +81-568-51-9512 Email:

Abstract

Malignant melanoma is resistant to various therapies, while its incidence has been dramatically increasing. Among various factors, sun exposure, particularly ultra violet (UV) irradiation is considered to induce melanomas. Gangliosides have been markers of neuro-ectoderm-derived cancers like malignant melanomas and gliomas, but they also play crucial roles in their malignant properties. GD3 regulates cell signalling transduced through membrane microdomains. Chronic inflammatory reactions toward noxious stimuli cause cumbersome diseases such as cancers and degeneration, and glycosylation is involved in those processes. Here, melanocytes did not respond to UVB, while keratinocytes responded to UVB by secreting various cytokines such as TNFα and IL-6. Furthermore, these cytokines induced expression of melanoma-associated ganglioside GD3 on melanocytes. Expression of GD3 does not necessarily induce melanomas, but may form microenvironments for the generation of melanomas after long-term continuation. Consequently, combination of DNA mutagenesis and chronic inflammatory reaction seems to be critical for the melanomagenesis. Thus, 1. Mechanisms for the induction of GD3 synthase gene by inflammatory cytokines. 2. Meaning of GD3 expression in melanocytes. 3. Linkage between GD3 expression in melanocytes and melanomagenesis. 4. Prevention of UV exposure, are proposed as urgent issues to be solved in the near future.

Keywords: Malignant melanoma; Gangliosides; Inflammatory cytokines

Introduction

Malignant melanoma is a refractory cancer resistant to various therapies such as chemotherapy [1] and radiation even when combined with BRAF inhibitors [2]. Incidence of melanoma has been dramatically increasing, i.e. the lifetime risk of melanoma in 1935 was one in 1500 persons and one in 75 persons in 2000 in US [3,4]. Although primary causes of melanomas are not known, various inducing factors have been reported [4]. Above all, sun exposure plays a primary and supporting role in most melanomas [4]. In sunlight, ultra violet (UV) irradiation is an environmental carcinogen, and has been considered to induce melanomas via DNA damaging, carcinogenic, inflammatory, and immunosuppressive properties [5]. This is now broadly noticed by not only medical researchers but also by environmental scientists [6], since destruction of stratospheric ozone levels is considered to increase chance of UV exposure of people [7].

Sialic acid-containing glycosphingolipids, gangliosides have been considered to be markers of neuro-ectoderm-derived cancers such as malignant melanomas and gliomas [8]. Majority of melanomas specifically express ganglioside GD3 on the cell surface [9-12], thereby being a target of antibody therapy [13]. Ganglioside GD2 and GM2 have been also considered to be melanoma-associated antigens [14,15]. Recently, however, these melanoma-associated gangliosides have been reported to play crucial roles in the malignant properties of melanomas based on the sugar-remodeling experiments [16]. For example, ganglioside GD3 enhances tyrosine phosphorylation of p130Cas, focal adhesion kinase, and paxillin upon stimulation with growth factors [16,17]. GD3 expression also increased phosphorylation levels of Src family kinase, Yes [18], and altered intracellular localization of integrins, leading to increased cell proliferation, invasion and adhesion to extracellular matrices [19]. Thus, gangliosides are involved in the regulation of cell signaling transduced through membrane microdomains, such as lipid rafts, detergent-insoluble glycolipid rafts or glycolipid-enriched microdomain/rafts [20,21].

Recently, many studies suggest that chronic inflammatory reactions toward intrinsic and extrinsic noxious stimuli cause more cumbersome diseases such as malignant transformation and degeneration of tissues, and glycosylation is involved in those processes [22]. For example, GM3-only mice lacking GM2/GD2 synthase and GD3 synthase undergo severe inflammatory reactions and subsequent neurodegeneration [23]. Knockout mice of either one gene also exhibited inflammatory reactions with less intensity [24]. Another example is knockout mice of A4glnt1 lacking α1,4-N-acetylglucosaminyltransferase 1 gene [25]. The mutant mice are deficient of a unique O-glycan structure expressed in deep layer of stomach membrane, and showed increased secretion of various inflammatory cytokines and growth factors, and subsequent occurrence of gastric adenocarcinomas (Figure 1) [25].

clinical-cellular-immunology-UVB-irradiation

Figure 1: UVB irradiation modulates inflammatory environments in skin. A). A scheme to show paracrine stimulation of melanocytes to induce ganglioside GD3. B). Induction of GD3 synthase gene and suppression of GM1/GD1b synthase in melanocytes as measured by qRT-PCR. Melanocytes were cultured for 2 days with the supernatant of HaCat cells that had been exposed to repeated UV irradiation, and gene expression was analyzed by qRT-PCR [26]. Cells cultured with fresh medium were used as controls (NC).

Here, what we are most interested in is that melanocytes did not respond to UVB exposure in terms of cytokine production and secretion [26], although they might undergo DNA damage by UVB. Consequently, keratinocytes responded to UVB exposure by secreting various cytokines such as TNFα, IL-6, IL-1β, and IL-8 etc. Furthermore, the fact that these cytokines secreted from UV-irradiated keratinocytes induced expression of melanoma-associated ganglioside GD3 on melanocytes [26]. Culture supernatants from those keratinocytes also suppressed GM1/GD1b synthase gene in melanocytes, that is now considered to be rather a suppressive antigen in the regulation of cancer properties [27,28]. Although expression of GD3 on melanocytes does not necessarily induce malignant transformation to melanomas, it may form microenvironments for the generation of melanomas. This kind of inflammatory environments around melanocytes might induce transformation of them after longterm continuation. Consequently, combination of DNA mutagenesis and chronic inflammatory reaction seems to be critical for the carcinogenic events (Figure 2).

clinical-cellular-immunology-Chronic-inflammation

Figure 2: Chronic inflammation results in malignant cancer or degeneration. Environmental stresses such as UVB irradiation bring about changes in glycolipid expression based on inflammatory microenvironments. Processes for prolonged inflammation leading to melanomagenesis should be clarified. How to control inflammatory reactions and probably how to regulate glycosylation might be pivotal as indicated.

UV irradiation is currently considered to induce p53-mediated up-regulation of proopiomelanocortin (POMC) in keratinocytes, leading to generation of α-MSH and β-endorphin. Since α-MSH is considered to promote pigment production via cAMP in melanocytes, cross-talk between inflammatory cytokine-derived signals and α-MSH signals seems to be of quite interest.

Thus, next issues to be solved are as follows:

• Mechanisms for the induction of GD3 synthase gene by inflammatory cytokines secreted from adjacent keratinocytes.

• Clarification of meaning of the induction of GD3 expression in melanocytes by inflammatory cytokines.

• Linkage between GD3 expression in melanocytes and melanomagenesis, i.e. how GD3 expression is involved in the transformation of melanocytes to melanomas.

• Lessons drawn from the results of this paper, leading to the prevention of the disease.

Why only GD3 is induced and no other gangiosides? Transcriptional regulation of ST8SIA1 (GD3 synthase) as well as epigenetic regulation of the gene needs to be investigated. GD3 has been known to be expressed on immature cells such as neuronal stem cells and also in activated cells such as activated T lymphocytes [29]. GD3 has been also considered to be associated with apoptosis by FAS/ FAS-ligand interaction [30]. Comparison of features between GD3- positive and GD3-negative melanocytes should be important, and would provide insights into this question. At this moment, GD3 expression is considered to reflect activation, de-differentiation, or adaptation to inflammatory environments. As described above, UV irradiation has multiple effects on the skin, including DNA changes, induction of reactive oxygen species, modulation of cutaneous immune system, and production of growth factors [31]. Generally, all these processes bring about inflammatory responses, promoting melanocyte survival and immunoevasion [31,32].

Conclusion

How GD3 expression upon UVB exposure leads melanocytes to transformation seems to be most esoteric question. Probably we need to consider general effects of long-term exposure of melanocytes to inflammatory cytokines and activation of related transcription factors on qualitative changes of cells [33]. As for preventive strategies of skin cancers, reduction of DNA photodamage by protection from the sun seems most efficient [34]. In order to regulate chronic inflammatory condition, aspirin and other non-steroidal anti-inflammatory drugs might be considered as chemoprevention agents [35].

Acknowledgement

I would acknowledge Dr. KO Lloyd for reading the manuscript.

References

  1. Ho RC (1995) Medical management of stage IV malignant melanoma. Medical issues. Cancer 75: 735-741.
  2. Gaudy-Marqueste C, Carron R, Delsanti C, Loundou A, Monestier S, et al. (2014) On demand Gamma-Knife strategy can be safely combined with BRAF inhibitors for the treatment of melanoma brain metastases. Ann Oncol 25: 2086-2091.
  3. Chang AE, Karnell LH, Menck HR (1998) The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83: 1664-1678.
  4. Volkovova K, Bilanicova D, Bartonova A, Letašiová S, Dusinska M (2012) Associations between environmental factors and incidence of cutaneous melanoma. Environ Health 11 Suppl 1: S12.
  5. Garibyan L, Fisher DE (2010) How sunlight causes melanoma. Curr Oncol Rep 12: 319-326.
  6. Hölzle E, Hönigsmann H (2005) [UV-radiation--sources, wavelength, environment]. J Dtsch Dermatol Ges 3 Suppl 2: S3-10.
  7. Madronich S, McKenzie RL, Björn LO, Caldwell MM (1998) Changes in biologically active ultraviolet radiation reaching the Earth's surface. J Photochem Photobiol B 46: 5-19.
  8. Lloyd KO, Old LJ (1989) Human monoclonal antibodies to glycolipids and other carbohydrate antigens: dissection of the humoral immune response in cancer patients. Cancer Res 49: 3445-3451.
  9. Portoukalian J, Zwingelstein G, Doré JF (1979) Lipid composition of human malignant melanoma tumors at various levels of malignant growth. Eur J Biochem 94: 19-23.
  10. Carubia JM, Yu RK, Macala LJ, Kirkwood JM, Varga JM (1984) Gangliosides of normal and neoplastic human melanocytes. Biochem Biophys Res Commun 120: 500-504.
  11. Dippold WG, Lloyd KO, Li LT, Ikeda H, Oettgen HF, et al. (1980) Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A 77: 6114-6118.
  12. Pukel CS, Lloyd KO, Travassos LR, Dippold WG, Oettgen HF, et al. (1982) GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med 155: 1133-1147.
  13. Houghton AN, Mintzer D, Cordon-Cardo C, Welt S, Fliegel B, et al. (1985) Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma. Proc Natl Acad Sci U S A 82: 1242-1246.
  14. Watanabe T, Pukel CS, Takeyama H, Lloyd KO, Shiku H, et al. (1982) Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J Exp Med 156: 1884-1889.
  15. Tai T, Paulson JC, Cahan LD, Irie RF (1983) Ganglioside GM2 as a human tumor antigen (OFA-I-1). Proc Natl Acad Sci U S A 80: 5392-5396.
  16. Hamamura K, Furukawa K, Hayashi T, Hattori T, Nakano J, et al. (2005) Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc Natl Acad Sci U S A 102: 11041-11046.
  17. Hamamura K, Tsuji M, Ohkawa Y, Nakashima H, Miyazaki S, et al. (2008) Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells. Biochim Biophys Acta 1780: 513-519.
  18. Hamamura K, Tsuji M, Hotta H, Ohkawa Y, Takahashi M, et al. (2011) Functional activation of Src family kinase yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3. J Biol Chem 286: 18526-18537.
  19. Ohkawa Y, Miyazaki S, Hamamura K, Kambe M, Miyata M, et al. (2010) Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains. J Biol Chem 285: 27213-27223.
  20. Harder T, Simons K (1997) Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr Opin Cell Biol 4: 534-42.
  21. Hakomori S, Yamamura S, Handa AK (1998) Signal transduction through glyco (sphingo) lipids. Introduction and recent studies on glyco(sphingo)lipid-enriched microdomains. Ann N Y Acad Sci 845: 1-10.
  22. Furukawa K, Ohmi Y, Kondo Y, Ohkawa Y, Tajima O, et al. (2015) Regulatory function of glycosphingolipids in the inflammation and degeneration. Arch Biochem Biophys 571: 58-65.
  23. Ohmi Y, Tajima O, Ohkawa Y, Mori A, Sugiura Y, et al. (2009) Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues. Proc Natl Acad Sci U S A 106: 22405-22410.
  24. Ohmi Y, Tajima O, Ohkawa Y, Yamauchi Y, Sugiura Y, et al. (2011) Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice. J Neurochem 116: 926-935.
  25. Karasawa F, Shiota A, Goso Y, Kobayashi M, Sato Y, et al. (2012) Essential role of gastric gland mucin in preventing gastric cancer in mice. J Clin Invest 122: 923-934.
  26. Miyata M, Ichihara M, Tajima O, Sobue S, Kambe M, et al. (2014) UVB-irradiated keratinocytes induce melanoma-associated ganglioside GD3 synthase gene in melanocytes via secretion of tumor necrosis factor a and interleukin 6. Biochem Biophys Res Commun 445: 504-510.
  27. Dong Y, Ikeda K, Hamamura K, Zhang Q, Kondo Y, et al. (2010) GM1?/?GD1b?/?GA1 synthase expression results in the reduced cancer phenotypes with modulation of composition and raft-localization of gangliosides in a melanoma cell line. Cancer Sci 101: 2039-2047.
  28. Furukawa K, Ohkawa Y, Yamauchi Y, Hamamura K, Ohmi Y, et al. (2012) Fine tuning of cell signals by glycosylation. J Biochem 151: 573-578.
  29. Yamashiro S, Okada M, Haraguchi M, Furukawa K, Lloyd KO, et al. (1995) Expression of alpha 2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes. Glycoconj J 12: 894-900.
  30. De Maria R, Lenti L, Malisan F, d'Agostino F, Tomassini B, et al. (1997) Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. 277: 1652-1655.
  31. Lo JA, Fisher DE (2014) The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. 346: 945-949.
  32. Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, et al. (2011) Interferon-γ links ultraviolet radiation to melanomagenesis in mice. Nature 469: 548-553.
  33. Govindarajan B, Bai X, Cohen C, Zhong H, Kilroy S, et al. (2003) Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling. J Biol Chem 278: 9790-9795.
  34. Seebode C, Lehmann J, Emmert S (2016) Photocarcinogenesis and Skin Cancer Prevention Strategies. Anticancer Res 36: 1371-1378.
  35. Goodman JR, Grossman D (2014) Aspirin and other NSAIDs as chemoprevention agents in melanoma. Cancer Prev Res (Phila) 7: 557-564.
Citation: Furukawa K, Miyata M, Kambe M, Takeuchi R, Bhuiyan RH, et al. (2017) Inflammatory Reactions in Microenvironments, Leading to Melanomagenesis. J Clin Cell Immunol 8:508.

Copyright: © 2017 Furukawa K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top